Dry Eye Disease

Disease State Hub

FDA Alerts

roundup

FDA Roundup: Generic Rosuvastatin, Psoriasis Recommendation, Dry Eye

07/21/2016

The FDA has approved generic forms of rosuvastatin and a new option for dry eye disease and has heard recommendations to approve a new psoriasis drug.

07/21/2016

Research Summaries

Research Summary

Water-Free Cyclosporine, 0.1% Superior to Vehicle in Treating Dry Eye Disease

06/10/2024

Anthony Calabro, MA

In this multicenter, phase 3 randomized-controlled trial, researchers evaluated the efficacy and safety of SHR8028, a water-free cyclosporine solution, 0.1%, compared with vehicle in patients with dry eye...

06/10/2024

Dry Eye Disease

Women, Postmenopausal Women Experience Severe Signs of Dry Eye

01/11/2023

Researchers compared the signs and symptoms of dry eye disease between men and women, and postmenopausal and premenopausal women.

01/11/2023

roundup

FDA Roundup: Generic Rosuvastatin, Psoriasis Recommendation, Dry Eye

07/21/2016

The FDA has approved generic forms of rosuvastatin and a new option for dry eye disease and has heard recommendations to approve a new psoriasis drug.

07/21/2016

research summary

New Treatment Application Significantly Reduced Symptomatology in Dry Eye Disease

07/01/2015

Researchers examined the efficacy of a sutureless dehydrated amniotic membrane under a specialized bandage contact lens for the treatment of dry eye disease.

07/01/2015

June 2024

Current Issue

June 2024

Volume 64

Issue 6